Exosome Hair Therapy Compared to Other Treatments
If you are researching hair loss treatment in any depth, you will quickly find that exosome therapy does not exist in isolation.
It sits in a landscape that includes licensed medicines, surgery, established clinic procedures and a growing number of regenerative options.
Understanding where exosome therapy fits, and where it does not, is the most useful thing we can do for anyone considering it.
Book your consultation
How to Use This Information
Each comparison guide covers the same ground: what the other treatment is, how it works, what the evidence shows, the UK regulatory position, and who each option suits. They are written for a reader who wants to understand the real differences, not for someone looking for reassurance that they have already made the right choice.
A few things that are true of all the comparisons before you start:
Some of the treatments listed have a stronger evidence base than the E50. PRP has 43 randomised controlled trials behind it. Finasteride and minoxidil have decades of licensed trial data. We state this plainly in the relevant guides, because a clinic that claims its own treatment has the best evidence for everything is not a clinic giving you accurate information.
Several treatments on this list are complementary rather than competing. Minoxidil, finasteride and exosome therapy work through different mechanisms. Many patients use more than one of these concurrently. The guides address this where it is relevant.
The right answer depends on your specific case. Pattern of loss, stage of miniaturisation, whether follicles are still present, and your personal circumstances all affect which treatment makes sense. No comparison page can substitute for a proper clinical assessment.
Exosome Therapy versus PRP
PRP (platelet-rich plasma) and exosome therapy are the two most-discussed regenerative hair treatments in the UK. PRP uses a concentrated preparation of platelets from your own blood, injected into the scalp.
It has the most developed evidence base of any regenerative option in this category: a 2025 meta-analysis of 43 RCTs covering 1,877 patients. Exosome therapy has a smaller evidence base but a different delivery profile: topical rather than injectable, standardised rather than variable. For patients weighing evidence depth against protocol preference, this guide covers both in full.
Exosome Therapy versus Minoxidil
Minoxidil is the most widely used hair loss treatment in the world, available over the counter in the UK, licensed for androgenetic alopecia in both men and women. It has a stronger evidence base than exosome therapy. It also requires daily lifelong application, and between 40 and 60 per cent of people do not respond to it due to a genetic enzyme variation.
We explain how the two treatments work differently, when they can be used together, and what to do if minoxidil has stopped working for you.
Exosome Therapy versus Finasteride
Finasteride 1mg (Propecia) is a prescription-only medicine licensed for male pattern hair loss. It suppresses the hormone responsible for follicle miniaturisation and has a strong evidence base from clinical trials. It is not available to women of childbearing age, requires daily use, and carries MHRA-documented risks including depression and sexual side effects.
We cover the evidence, the side effect picture honestly, and how finasteride and exosome therapy differ in what they do.
Exosome Therapy versus LLLT (Red Light Therapy)
Low-level laser therapy has a solid and growing evidence base: a 2025 meta-analysis of 38 studies and 3,098 patients, with one RCT finding it non-inferior to minoxidil. The consumer category of "red light therapy" is much broader and less consistent.
We explain the difference between calibrated clinical LLLT and consumer devices, how photobiomodulation works, and how its mechanism compares to exosome therapy.
Exosome Therapy versus Hair Transplant
Hair transplant surgery (FUE or FUT) and exosome therapy are not really competing for the same patient. Transplants are for people whose follicles are gone and need to be relocated. Exosome therapy is for people whose follicles are still present but miniaturising.
We explain the distinction, when surgery is the right answer rather than a non-surgical option, and the emerging evidence for exosomes as a complementary peri-transplant treatment to support graft survival and reduce shock loss.
Exosome Therapy versus Stem Cell Therapy
"Stem cell therapy for hair loss" is one of the most searched and most misused terms in hair restoration. It covers at least three clinically distinct things: live stem cell injections (SVF/ADSC), stem cell-derived exosomes (MSC/ADSC-exosomes), and treatments like the E50 that are exosome-based but not stem cell-derived.
We untangle the taxonomy, explains the evidence and UK regulatory position for each category, and is clear about where the E50 sits and where it does not.
Exosome Therapy versus Mesotherapy
Mesotherapy delivers a cocktail of vitamins, minerals, amino acids and sometimes prescription medicines by scalp injection. It has twelve published studies behind it but no standard formulation: the cocktail is different in every clinic and every study, which makes its evidence difficult to interpret.
We explain the cocktail problem, what mesotherapy can and cannot claim based on the published evidence, how it compares mechanistically to exosome therapy, and what UK regulatory requirements apply when prescription medicines are involved.
Is Exosome Hair Restoration Therapy Right For You?
In a world of endless serums, tinctures and procedures it's easy to feel like you're going round in circles.
Exosome Therapy isn't for everybody, and we're upfront about that.
Our 2 Minute Suitability Quiz helps you get a clear picture on whether to proceed with this Treatment or not.